BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9279332)

  • 1. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.
    Berenguer J; Rodríguez-Tudela JL; Richard C; Alvarez M; Sanz MA; Gaztelurrutia L; Ayats J; Martinez-Suarez JV
    Medicine (Baltimore); 1997 Jul; 76(4):256-65. PubMed ID: 9279332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection and colonization by Scedosporium prolificans].
    López L; Gaztelurrutia L; Cuenca-Estrella M; Monzón A; Barrón J; Hernández JL; Pérez R
    Enferm Infecc Microbiol Clin; 2001; 19(7):308-13. PubMed ID: 11747789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
    Barbaric D; Shaw PJ
    Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
    Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
    Seidel D; Hassler A; Salmanton-García J; Koehler P; Mellinghoff SC; Carlesse F; Cheng MP; Falces-Romero I; Herbrecht R; Jover Sáenz A; Klimko N; Mareş M; Lass-Flörl C; Soler-Palacín P; Wisplinghoff H; Cornely OA; Pana Z; Lehrnbecher T
    Int J Infect Dis; 2020 Mar; 92():114-122. PubMed ID: 31863876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.
    Rodriguez-Tudela JL; Berenguer J; Guarro J; Kantarcioglu AS; Horre R; de Hoog GS; Cuenca-Estrella M
    Med Mycol; 2009 Jun; 47(4):359-70. PubMed ID: 19031336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope
    Seidel D; Meißner A; Lackner M; Piepenbrock E; Salmanton-García J; Stecher M; Mellinghoff S; Hamprecht A; Durán Graeff L; Köhler P; Cheng MP; Denis J; Chedotal I; Chander J; Pakstis DL; Los-Arcos I; Slavin M; Montagna MT; Caggiano G; Mares M; Trauth J; Aurbach U; Vehreschild MJGT; Vehreschild JJ; Duarte RF; Herbrecht R; Wisplinghoff H; Cornely OA
    Crit Rev Microbiol; 2019 Feb; 45(1):1-21. PubMed ID: 30628529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal Scedosporium prolificans infection in a paediatric patient with acute lymphoblastic leukaemia.
    Song MJ; Lee JH; Lee NY
    Mycoses; 2011 Jan; 54(1):81-3. PubMed ID: 19664020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy.
    Pickles RW; Pacey DE; Muir DB; Merrell WH
    J Infect; 1996 Nov; 33(3):193-7. PubMed ID: 8945709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.
    Ochi Y; Hiramoto N; Takegawa H; Yonetani N; Doi A; Ichikawa C; Imai Y; Ishikawa T
    Int J Hematol; 2015 Jun; 101(6):620-5. PubMed ID: 25630434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    Wiederhold NP; Law D; Birch M
    J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
    Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
    Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.
    Alvarez M; Lopez Ponga B; Rayon C; Garcia Gala J; Roson Porto MC; Gonzalez M; Martinez-Suarez JV; Rodriguez-Tudela JL
    J Clin Microbiol; 1995 Dec; 33(12):3290-5. PubMed ID: 8586719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
    Solé A
    Rev Iberoam Micol; 2011; 28(3):139-42. PubMed ID: 21700235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
    J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
    Fernandez Guerrero ML; Askari E; Prieto E; Gadea I; Román A
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1321-4. PubMed ID: 21455664
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
    Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.
    Johnson LS; Shields RK; Clancy CJ
    Transpl Infect Dis; 2014 Aug; 16(4):578-87. PubMed ID: 24962102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
    Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scedosporium prolificans: an emerging pathogen in France?
    Grenouillet F; Botterel F; Crouzet J; Larosa F; Hicheri Y; Forel JM; Helias P; Ranque S; Delhaes L
    Med Mycol; 2009 Jun; 47(4):343-50. PubMed ID: 19085456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.